Wikidata

(Q37594993)

English

Current status and perspectives of tyrosine kinase inhibitor treatment in the posttransplant period in patients with chronic myelogenous leukemia (CML).

scientific article published on 08 September 2009

In more languages

Statements

title
Current status and perspectives of tyrosine kinase inhibitor treatment in the posttransplant period in patients with chronic myelogenous leukemia (CML). (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
19744571
retrieved
21 August 2017
author name string
Evgeny Klyuchnikov
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
19744571
retrieved
21 August 2017
Nicolaus Kröger
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
19744571
retrieved
21 August 2017
Tim H Brummendorf
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
19744571
retrieved
21 August 2017
Bettina Wiedemann
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
19744571
retrieved
21 August 2017
Axel Rolf Zander
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
19744571
retrieved
21 August 2017
publication date
8 September 2009
1 reference
stated in
Europe PubMed Central
PubMed ID
19744571
retrieved
21 August 2017
page(s)
301-310
1 reference
stated in
Europe PubMed Central
PubMed ID
19744571
retrieved
21 August 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q37594993&oldid=1565141856"